We are extremely excited and thankful to the American Cancer Society and the Harper Cancer Research Institute for facilitating this seed grant for our work on label-free targeting of undruggable cancer cells. We intend to target non-targetable cancer cells by tuning the force exerted by label-free nanomaterials at the cell membrane to selectively permeabilize the …
Category Archive: chemotherapeutics
Feb 14
American Cancer Society Seed Grant Awarded to us to Develop a Label-Free, Precise Chemotherapeutic Delivery to Metastatic Breast Cancer Cells In Vivo
Categories:
AD&T Notre Dame, American Cancer Society, Berthiaume Institute for Precision Health, chemotherapeutics, Harper Cancer Research Institute, Label-free, magnetoelectrics, metastatic cancer cells
by Prakash
Tags: NDNano
Recent Posts
- Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL) August 30, 2024
- Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa August 21, 2024
- Precision Health and Diagnostics Session Chair at Techconnect World Innovation Conference (2024) June 19, 2024
- MTEC Annual meeting in Baltimore MD (May 24, 2024) May 24, 2024
- Nallathamby Lab’s Kevin Armknecht is Invited to Present at the Midwest Microscopy and Microanalysis Workshop 2024 May 7, 2024
Archives
Categories
NIH Funding Opportunities
- Notice to Applicants That the Simplified Review Framework Will be Applied to All Relevant Applications for August/October 2025 Councils May 9, 2025Notice NOT-OD-25-116 from the NIH Guide for Grants and Contracts
- Notice of Change: Expiration of RFA-NS-24-019: HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) May 8, 2025Notice NOT-NS-25-024 from the NIH Guide for Grants and Contracts
- Notice of Need to Rescind NOT-AT-20-017 "NCCIH Policy Change to Budget Limit and Grant Durations for SBIR/STTR Phase I and Phase II Applications" to update NCCIH Policy Change to Budget Limit and Grant Durations for SBIR/STTR Phase I and Phase May 8, 2025Notice NOT-AT-25-004 from the NIH Guide for Grants and Contracts
- Updated NIH Processes for No-Cost Extensions May 7, 2025Notice NOT-OD-25-110 from the NIH Guide for Grants and Contracts
- Implementation Update: Improving the Safety and Security of Biological Research May 7, 2025Notice NOT-OD-25-112 from the NIH Guide for Grants and Contracts
- Notice of Intent to Publish the re-issuance of the Notice of Funding Opportunity (NOFO) Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) May 5, 2025Notice NOT-TR-25-008 from the NIH Guide for Grants and Contracts
Recent Comments